Bromelain in Obesity Therapy: A Review of Anti-Inflammatory and Metabolic Mechanisms
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178347 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yashvi Sethia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Students' Scientific Club, Department of Human Immunology, Faculty of Medicine, Medical College of Rzeszow University, University of Rzeszow, 35-959 …. Hauptthemen laut MEDLINE: Bromelains, Obesity, Anti-Inflammatory Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The increasing prevalence of obesity, a chronic disease, necessitates the development and evaluation of evidence-based prevention and intervention strategies tailored to heterogeneous populations. Certain fruits, including papaya and pineapple (Ananas comosus), have been investigated as potential dietary components in obesity management. In the context of obesity and chronic low-grade inflammation, bromelain, a proteolytic enzyme derived from pineapple, is a widely studied phytotherapeutic agent that acts through multiple mechanisms intersecting immune and metabolic pathways. This narrative review summarizes current evidence on the effects of bromelain in obesity, low-grade inflammation, and related metabolic disturbances. Searches of the literature were conducted in Google Scholar, PubMed, and Scopus databases. This review incorporates findings from in vitro, animal, and human studies. We outline the mechanisms and evidence supporting the therapeutic efficacy of bromelain, emphasizing its implications for obesity management in clinical settings. Bromelain has been shown to exert significant anti-inflammatory activity and may modulate adipocyte metabolism, potentially alleviating comorbidities associated with excess adiposity. Although its effects on immune cells are relatively well described, the mechanisms underlying bromelain’s actions on adipocytes remain incompletely understood.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Students' Scientific Club, Department of Human Immunology, Faculty of Medicine, Medical College of Rzeszow University, University of Rzeszow, 35-959 Rzeszow, Poland.
- Department of Dietetics, Faculty of Health Sciences and Psychology, Collegium Medicum, University of Rzeszow, 35-959 Rzeszow, Poland.
- Department of Human Immunology, Faculty of Medicine, Collegium Medicum, University of Rzeszow, 35-959 Rzeszow, Poland.
- Laboratory for Translational Research in Medicine, Centre for Innovative Research in Medical and Natural Sciences, Medical College of Rzeszow University, University of Rzeszow, 35-959 Rzeszow, Poland.
ORCID-Profile: Ewelina Polak-Szczybyło, Jacek Tabarkiewicz
Zitieren
APA
Sethia, Y., Polak-Szczybyło, E., & Tabarkiewicz, J. (2025). Bromelain in Obesity Therapy: A Review of Anti-Inflammatory and Metabolic Mechanisms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178347
Vancouver
Sethia Y, Polak-Szczybyło E, Tabarkiewicz J. Bromelain in Obesity Therapy: A Review of Anti-Inflammatory and Metabolic Mechanisms. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178347
BibTeX
@article{Sethia2025,
author = {Sethia, Yashvi and Polak-Szczybyło, Ewelina and Tabarkiewicz, Jacek},
title = {Bromelain in Obesity Therapy: A Review of Anti-Inflammatory and Metabolic Mechanisms},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178347}
}
EUVIMED